Live Breaking News & Updates on Fabio Fiallo

Stay updated with breaking news from Fabio fiallo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ARCA biopharma (NASDAQ:ABIO) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a report released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Trading Up 3.3 % Shares of NASDAQ:ABIO opened at $1.64 on Tuesday. ARCA biopharma has a one year low of $1.56 and a […] ....

Virtu-financial , Company-profile , Nasdaq , Charles-schwab-investment-management-inc , Renaissance-technologies , Free-report , Street-group , Schwab-investment-management , Get-free-report , Arca-biopharma , Nasdaq-abio

StockNews.com Initiates Coverage on ARCA biopharma (NASDAQ:ABIO)

StockNews.com initiated coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a report issued on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance NASDAQ:ABIO opened at $1.68 on Friday. ARCA biopharma has a 52 week low of $1.61 and a 52 week high of […] ....

Charles-schwab-investment-management-inc , Virtu-financial , Renaissance-technologies , Nasdaq , Free-report , Get-free-report , Schwab-investment-management , Street-group , Arca-biopharma , Nasdaq-abio , Fabio

ARCA biopharma (NASDAQ:ABIO) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance ABIO opened at $1.66 on Friday. ARCA biopharma has a one year low of $1.61 and a one year high […] ....

Virtu-financial , Nasdaq , Renaissance-technologies , Charles-schwab-investment-management-inc , Free-report , Get-free-report , Schwab-investment-management , Street-group , Arca-biopharma , Nasdaq-abio , Fabio

ARCA biopharma (NASDAQ:ABIO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance NASDAQ ABIO opened at $1.70 on Friday. The business’s 50 day moving average price is $1.81 and its 200-day moving average […] ....

Nasdaq , Renaissance-technologies , Virtu-financial , Charles-schwab-investment-management-inc , Free-report , Get-free-report , Schwab-investment-management , Street-group , Arca-biopharma , Nasdaq-abio , Fabio

ARCA biopharma (NASDAQ:ABIO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance Shares of NASDAQ ABIO opened at $1.71 on Friday. ARCA biopharma has a one year low of $1.67 […] ....

Charles-schwab-investment-management-inc , Nasdaq , Virtu-financial , Renaissance-technologies , Free-report , Get-free-report , Street-group , Schwab-investment-management , Arca-biopharma , Nasdaq-abio , Fabio